Bradenton, FL, United States of America

Yong Shen

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Arizona State University. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Shen. Retrieved from https://idiyas.com/inventor/yong-shen-mr4zxbdy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Yong Shen

Introduction

Yong Shen is a notable inventor based in Bradenton, Florida, who has made significant contributions to the field of biomedical research. He holds two patents that focus on therapeutic agents for neurological diseases. His work is crucial in developing treatments that target specific proteins associated with these conditions.

Latest Patents

Yong Shen's latest patents include bispecific antibody fragments designed for neurological disease proteins and methods of use. The present invention relates to therapeutic agents comprising bispecific recombinant antibody fragments that selectively clear proteins associated with neurological diseases. These innovative therapeutic agents aim to treat various neurological disorders effectively.

Career Highlights

Yong Shen is affiliated with Arizona State University, where he conducts research and develops his inventions. His work is characterized by a strong focus on addressing complex medical challenges through innovative solutions. His contributions to the field have garnered attention and respect from peers and the scientific community.

Collaborations

Yong Shen collaborates with Michael Sierks, who is also involved in research related to his patents. Their partnership enhances the potential for breakthroughs in the treatment of neurological diseases.

Conclusion

Yong Shen's innovative work in developing bispecific antibody fragments represents a significant advancement in the treatment of neurological diseases. His contributions are paving the way for new therapeutic approaches that could improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…